The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAVV.L Regulatory News (AVV)

  • There is currently no data for AVV

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

30 Jul 2019 13:25

RNS Number : 2306H
AVEVA Group PLC
30 July 2019
 

NOTIFICATION OF TRANSACTIONS OF DIRECTOR/PERSON DISCHARGING MANAGERIAL RESPONSIBILITY AND CONNECTED PERSONS

 

1

Name of the issuer

AVEVA GROUP PLC

2

State whether the notification relates to (i) a transaction notified in accordance with DR 3.1.4DR(1)(a); or

 

(ii) DR3.1.4(R) (1)(b) a disclosure made in accordance with section 324 (as extended by section 328) of the Companies Act 1985; or

 

(iii) both (i) and (ii)

 

NOTIFICATION UNDER (i)

 

3

Name of person discharging managerial responsibilities/director

 

SEE ATTACHED SCHEDULE

4

State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

N/A

 

5

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest

HOLDING IN RESPECT OF PERSON REFERRED TO IN 3 ABOVE

6

Description of shares (including class), debenture or derivatives or financial instruments relating to shares

 

OPTIONS TO ACQUIRE ORDINARY SHARES OF 35/9 PENCE EACH

 

7

Name of registered shareholder(s) and, if more than one, the number of shares held by each of them

N/A

 

8

State the nature of the transaction

 

OPTION GRANTS BY AVEVA GROUP PLC UNDER THE AVEVA GROUP DEFERRED SHARE BONUS PLAN

 

9

Number of shares, debentures or financial instruments relating to shares acquired

SEE ATTACHED SCHEDULE

 

10

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

SEE ATTACHED SCHEDULE

11

Number of shares, debentures or financial instruments relating to shares disposed

N/A

 

12

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage

N/A

13

Price per share of value of transaction

 

NIL

14

Date and place of transaction

 

26 JULY 2019, CAMBRIDGE

 

15

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

SEE ATTACHED SCHEDULE

 

16

Date issuer informed of transaction

 

26 JULY 2019

 17

Date of grant

26 JULY 2019

18

Period during which or date on which it can be exercised

SEE ATTACHED SCHEDULE

 

19

Total amount paid (if any) for grant of the option

NIL

 

20

Description of shares or debentures involved (class and number)

N/A

21

Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

SEE ATTACHED SCHEDULE

 

22

Total number of shares or debentures over which options held following notification

SEE ATTACHED SCHEDULE

23

Any additional information

 

 

SEE ATTACHED SCHEDULE

24

Name of contract and telephone number for queries

 

DAVID WARD 01223 556655

 

SCHEDULE

The names of the persons discharging managerial responsibilities ("PDMRs") in respect of whom this notification is made are:

 

Craig Hayman

James Kidd

David Ward

Andrew McCloskey

Lisa Johnston

Mark Cooper

Ravi Gopinath

Steen Lomholt-Thomsen

 

On 26 July 2019, AVEVA Group plc (the "Company") granted options to acquire ordinary shares of 35/9 pence each in the Company in favour of each of the above-named PDMRs under the terms of the AVEVA Group Deferred Share Bonus Plan (the "Deferred Share Scheme").  

These options have been granted to serve as the mechanism to deliver ordinary shares of 35/9 pence each in the Company ("shares") on a deferred basis to recipients as a deferred bonus in respect of the financial year ended 31 March 2019.

 

The number of shares in respect of which an option was granted to each PDMR is set against their name below: 

 

PDMR

Option Grant

Andrew McCloskey

3,227

Craig Hayman

8,618

James Kidd

6,155

David Ward

3,878

Lisa Johnston

1,588

Mark Cooper

2,465

Ravi Gopinath

 6,893

Steen Lomholt-Thomsen

4,170

Total

 

 

 The options each have the following principal terms:

 

·; Provided that the option holder remains an employee or director of the AVEVA Group, an option may normally be exercised as to one-third of the shares under option on each of 23 June 2020, 2021, 2022. 

 

·; Following the death of an option holder, or on a takeover, reconstruction or amalgamation, or voluntary winding up of the Company, the option may be exercised in full to the extent that it has not already been exercised.

 

·; No amount has been paid or is payable for the grant of the option; no exercise price is payable on exercise of the option.

 

While the option will be treated as void if the option holder fails to return an acceptance notice in the period established by the rules of the scheme pursuant to which these options have been granted, the Company anticipates that such an acceptance notice will be given by each of the PDMRs in respect of whom this notification is made. The Company will issue a further RNS notification if, contrary to expectation, such an acceptance notice is not given by any of the PDMRs.

 

For each of these PDMRs, the total number of shares beneficially held and the total number of shares over which options to acquire shares are held following the grant of these options is respectively:

 

PDMR

Shares held

Shares under option

Craig Hayman

-

390,788

Andrew McCloskey

-

15,586

James Kidd

23,809

 133,299

David Ward

5,967

74,940

Lisa Johnston

-

14,434

Mark Cooper

-

11,245

Ravi Gopinath

-

26,654

Steen Lomholt-Thomsen

3,603

99,633

 

Enquiries:

Telephone:

AVEVA Group plc

 

David Ward, Deputy CFO and Company Secretary

+44 (0)1223 556655

Claire Denton, Deputy Company Secretary and General Counsel

+44 (0)1223 556655

 

 

FTI Consulting

Telephone:

Ed Bridges/Dwight Burden

+44 (0)20 3727 1400

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHURAURKWABOAR
Date   Source Headline
18th Jan 20233:20 pmRNSForm 8.3 - AVEVA Group plc
18th Jan 20232:27 pmRNSForm 8.3 - AVEVA Group plc
18th Jan 20231:59 pmRNSForm 8.3 - AVEVA GROUP PLC
18th Jan 20231:11 pmEQSForm 8.3 - The Vanguard Group, Inc.: AVEVA Group plc
18th Jan 202312:02 pmRNSForm 8.5 (EPT/NON-RI)-AVEVA Group plc Amend
18th Jan 202311:11 amRNSForm 8.5 (EPT/RI) - Aveva Group Plc
18th Jan 202311:00 amRNSSCHEME OF ARRANGEMENT BECOMES EFFECTIVE
18th Jan 20239:58 amRNSForm 8.5 (EPT/NON-RI)-AVEVA Group plc
18th Jan 20239:52 amRNSForm 8.3 - Aveva Group Plc
18th Jan 20239:52 amRNSForm 8.5 (EPT/RI)-AVEVA Group plc
18th Jan 20239:10 amRNSForm 8.5 (EPT/RI)
18th Jan 20237:30 amRNSSuspension- Aveva Group PLC
17th Jan 20233:20 pmRNSForm 8.3 - AVEVA Group plc
17th Jan 20231:23 pmRNSForm 8.3 - AVEVA GROUP PLC
17th Jan 20231:04 pmRNSForm 8.3 - Aveva Group PLC
17th Jan 202312:28 pmRNSForm 8.3 -AVEVA GROUP PLC
17th Jan 202310:38 amRNSForm 8.5 (EPT/RI) - Aveva Group Plc
17th Jan 202310:33 amRNSISSUE AND ALLOTMENT OF NEW AVEVA SHARES
17th Jan 202310:22 amRNSForm 8.3 - Aveva Group Plc
17th Jan 202310:19 amRNSForm 8.5 (EPT/NON-RI)-AVEVA Group plc
17th Jan 202310:10 amRNSForm 8.5 (EPT/RI)-AVEVA Group plc
16th Jan 20233:28 pmRNSCOURT SANCTION OF SCHEME
16th Jan 20233:20 pmRNSForm 8.3 - AVEVA Group plc
16th Jan 20231:30 pmEQSForm 8.3 - The Vanguard Group, Inc.: AVEVA Group plc
16th Jan 202311:24 amRNSForm 8.5 (EPT/RI) - Aveva Group Plc
16th Jan 202311:17 amRNSForm 8.3 - AVEVA GROUP PLC
16th Jan 202311:14 amRNSForm 8.3 - Aveva Group Plc
16th Jan 202310:12 amRNSForm 8.5 (EPT/NON-RI)-AVEVA Group plc
16th Jan 202310:05 amRNSForm 8.5 (EPT/RI)-AVEVA Group plc
16th Jan 20238:53 amRNSForm 8.5 (EPT/RI)
13th Jan 20236:12 pmRNSAveva Group
13th Jan 20233:20 pmRNSForm 8.3 - AVEVA Group plc
13th Jan 20231:33 pmEQSForm 8.3 - The Vanguard Group, Inc.: AVEVA Group plc
13th Jan 202311:20 amRNSForm 8.3 - AVEVA GROUP PLC
13th Jan 202310:26 amRNSForm 8.5 (EPT/RI) - Aveva Group Plc
13th Jan 202310:18 amRNSForm 8.5 (EPT/NON-RI)-AVEVA Group plc
13th Jan 202310:15 amRNSForm 8.5 (EPT/RI)-AVEVA Group plc
13th Jan 20239:01 amRNSForm 8.5 (EPT/RI)
13th Jan 20237:00 amRNSForm 8.3 - AVEVA GROUP PLC Amend
12th Jan 20233:20 pmRNSForm 8.3 - AVEVA Group plc
12th Jan 20233:06 pmRNSForm 8.3 - AVEVA Group plc
12th Jan 20231:24 pmEQSForm 8.3 - The Vanguard Group, Inc.: AVEVA Group plc
12th Jan 202312:05 pmRNSForm 8.3 - AVEVA GROUP PLC
12th Jan 202311:23 amRNSForm 8.5 (EPT/RI) Aveva Group Plc
12th Jan 202310:28 amBUSForm 8.3 - AVV LN Equity 11-January-23 Decrease in Traded Position Disclosure
12th Jan 202310:23 amRNSForm 8.5 (EPT/NON-RI) - AVEVA Group plc
12th Jan 202310:17 amRNSForm 8.5 (EPT/RI) - AVEVA Group plc
12th Jan 20238:35 amRNSForm 8.5 (EPT/RI)
11th Jan 20236:00 pmRNSAveva Group
11th Jan 20233:20 pmRNSForm 8.3 - AVEVA Group plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.